The global Injectable Drug Delivery Formulation market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Injectable Drug Delivery Formulation volume and value at global level, regional level and company level. From a global perspective, this report represents overall Injectable Drug Delivery Formulation market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Injectable Drug Delivery Formulation in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Injectable Drug Delivery Formulation manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Becton, Dickinson and Company (U.S.)
Baxter International Inc. (U.S.)
Gerresheimer AG (Germany)
Pfizer, Inc. (U.S.)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations

Segment by Application
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others